You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally advanced/unresectable

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Unresectable Pancreatic Adenocarcinoma Trial (Padeliporfin Vascular Targeted Photodynamic (VTP) therapy)

Not yet recruiting
  • Locally Advanced Unresectable Pancreatic Adenocarcinoma
  • Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
  • (no location specified)
Jun 25, 2023

Locally Advanced Unresectable Esophageal Squamous Carcinoma Trial in Jinan, Tianjin (Docetaxel for Injection (Albumin-bound),

Not yet recruiting
  • Locally Advanced Unresectable Esophageal Squamous Carcinoma
  • Docetaxel for Injection (Albumin-bound)
  • +4 more
  • Jinan, Shandong, China
  • +1 more
Nov 16, 2023

Solid Tumor Trial in Zhengzhou, Jinan (RC148)

Not yet recruiting
  • Solid Tumor
  • Zhengzhou, Henan, China
  • +2 more
Aug 24, 2023

Advanced Solid Tumor Trial in Shanghai (RC118, Toripalimab)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    hongshan Hospital Affiliated to Fudan University
Sep 14, 2023

Locally Advanced Unresectable or Metastatic Solid Tumors Trial in Randwick, Sunshine Coast, Clayton (IBI354)

Not yet recruiting
  • Locally Advanced Unresectable or Metastatic Solid Tumors
  • IBI354
  • Randwick, New South Wales, Australia
  • +2 more
Dec 8, 2022

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric

Available
  • Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer
  • +3 more
  • Morristown, New Jersey
    AMG Hematology/Oncology
Sep 15, 2023

Hepatocellular Carcinoma Trial (Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle
  • (no location specified)
Jun 12, 2023

Locally Advanced Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial (RP3,

Not yet recruiting
  • Locally Advanced Hepatocellular Carcinoma
  • +2 more
  • RP3
  • +2 more
  • (no location specified)
Feb 8, 2023

Breast Cancer Trial (RO7247669, Pembrolizumab, Nab-Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
May 2, 2023

Melanoma, Urothelial Carcinoma, Renal Cell Carcinoma Trial in Auchenflower (RC198 Injection)

Not yet recruiting
  • Melanoma
  • +5 more
  • RC198 Injection
  • Auchenflower, Queensland, Australia
    Research Site
May 17, 2023

Locally Advanced Unresectable or Metastatic Solid Tumors Trial in Benowa (IBI343)

Not yet recruiting
  • Locally Advanced Unresectable or Metastatic Solid Tumors
  • Benowa, Queensland, Australia
    Pindara Private Hospital
Jul 11, 2022

Renal Cell Carcinoma Trial in Beijing, Seoul (RO7247669, Tiragolumab, Pembrolizumab)

Recruiting
  • Renal Cell Carcinoma
  • Beijing, China
  • +1 more
Mar 28, 2023

Locally Advanced Unresectable Gastric Adenocarcinoma Trial in Tianjin (Oxaliplatin, Capecitabine, Cadonilimab)

Not yet recruiting
  • Locally Advanced Unresectable Gastric Adenocarcinoma
  • Tianjin, Tianjin, China
    Xuewei Ding
Aug 2, 2023

Pancreatic Cancer Trial in Rozzano (SBRT and chemo)

Completed
  • Pancreatic Cancer
  • SBRT and chemotherapy
  • Rozzano, Milan, Italy
    Humanitas Research Hospital
Sep 14, 2022

Solid Tumor Trial (TXN10128)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Jul 29, 2023

Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Toripalimab, Paclitaxel-albumin, Nedaplatin)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Oct 25, 2022

MSI-H/dMMR Solid Tumor Trial in Guangzhou (AK104)

Terminated
  • MSI-H/dMMR Solid Tumor
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Oct 17, 2022

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

Not yet recruiting
  • Urothelial Carcinoma
    • (no location specified)
    Jun 5, 2023

    Pancreatic Cancer Non-resectable Trial in Shanghai (Carbon ion radiotherapy)

    Not yet recruiting
    • Pancreatic Cancer Non-resectable
    • Carbon ion radiotherapy
    • Shanghai, China
      Shanghai Proton and Heavy Ion Center
    Jun 22, 2022

    Locally Advanced Unresectable or Metastatic Solid Tumors Trial in China (SG1906)

    Recruiting
    • Locally Advanced Unresectable or Metastatic Solid Tumors
    • Beijing, Beijing, China
    • +8 more
    May 12, 2023

    Unresectable Pancreatic Cancer Trial in Baltimore (NanoKnife IRE System)

    Active, not recruiting
    • Unresectable Pancreatic Cancer
    • NanoKnife IRE System
    • Baltimore, Maryland
      University of Maryland Medical Center
    Jan 30, 2023

    Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies Trial in Chuo-ku (ASP1948)

    Completed
    • Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
    • Chuo-ku, Tokyo, Japan
      Site JP810001
    Jan 17, 2023

    Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

    Terminated
    Has Results
    • Locally Advanced Malignant Solid Neoplasm
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 22, 2022

    Metastatic or Locally-advanced Unresectable Breast Cancer Trial in New York (BYL719, Letrozole, Exemestane)

    Completed
    • Metastatic or Locally-advanced Unresectable Breast Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 1, 2022

    Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma, Determine Efficacy of Liver Transplantation After Neoadjuvant

    Not yet recruiting
    • Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
    • Determine Efficacy of Liver Transplantation After Neoadjuvant Systemic Therapy in Patients With Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
    • Liver Transplant
    • Newark, New Jersey
    • +1 more
    Nov 14, 2023